PET-CT Surveillance Frequency for Ovarian Cancer
PET-CT should NOT be used for routine surveillance in ovarian cancer patients at any time interval, including one year post-diagnosis. 1
Evidence-Based Surveillance Approach
The Society of Gynecologic Oncologists explicitly states there is insufficient data to support routine use of PET-CT (or any radiographic imaging) for ovarian cancer surveillance at all time points: 0-12 months, 12-24 months, 24-36 months, 3-5 years, and beyond 5 years. 1
Recommended Surveillance Schedule at 1 Year Post-Diagnosis
At 12 months post-diagnosis, patients fall into the 12-24 month surveillance window where the following is recommended: 1
- Clinical examination every 3 months including comprehensive symptom review, speculum examination, bimanual pelvic examination, and rectovaginal examination 1
- CA-125 monitoring is optional (should be discussed with patient regarding pros and cons) 1
- No routine imaging of any kind including PET-CT, CT, MRI, chest x-ray, or ultrasound 1
When PET-CT IS Indicated
PET-CT should only be obtained when recurrence is suspected based on: 1
Diagnostic Algorithm for Suspected Recurrence
When recurrence is suspected, the recommended imaging approach is: 1
- First-line: CT chest/abdomen/pelvis with IV contrast to determine disease extent 1
- Second-line: PET-CT is used as an adjunct when CT findings are indeterminate or equivocal 1
Performance Characteristics of PET-CT
While PET-CT demonstrates variable sensitivity (45-100%) and specificity (40-100%) with overall diagnostic accuracy of 95%, this does not justify routine surveillance use. 1 Research shows PET-CT is particularly valuable for detecting recurrence when CA-125 is rising but conventional CT/MRI is negative or inconclusive. 2, 3, 4
Critical Rationale Against Routine Surveillance Imaging
The guidelines explicitly recommend against routine imaging because: 1
- No mortality benefit: Early detection of asymptomatic recurrence has not been proven to improve survival outcomes 1
- Limited treatment options: Recurrent ovarian cancer remains largely incurable with second-line therapies offering only short-term progression-free survival 1
- Cost and radiation exposure: Routine PET-CT surveillance exposes patients to unnecessary radiation and healthcare costs without proven benefit 1
Important Nuance from Research
A 2009 meta-analysis found PET-CT had the highest pooled sensitivity (0.91) for detecting recurrent disease, with an AUC of 0.9555, superior to CT alone (AUC 0.8845). 3 However, this diagnostic accuracy in symptomatic or high-suspicion patients does not translate to benefit in asymptomatic routine surveillance, which is why guidelines maintain their position against routine use. 1
Common Pitfalls to Avoid
- Do not order "routine" or "surveillance" PET-CT scans at any predetermined interval 1
- Do not substitute PET-CT for clinical examination - physical exam remains the cornerstone of surveillance 1
- Do not obtain PET-CT based solely on patient anxiety without objective clinical indicators of recurrence 1
- Do not skip the CT scan and go directly to PET-CT when recurrence is suspected - CT should be obtained first 1